Transarterial chemoembolization plus lenvatinib with or without programmed death-1 inhibitors for patients with unresectable hepatocellular carcinoma: A propensity score matching study

Transarterial chemoembolization plus lenvatinib with or without programmed death-1 inhibitors for patients with unresectable hepatocellular carcinoma: A propensity score matching study

PurposeWe conducted a retrospective study to compare transarterial chemoembolization (TACE) plus lenvatinib plus programmed death-1 (PD-1) inhibitors with TACE plus lenvatinib in patients with unresectable hepatocellular carcinoma (HCC).Patients and methodsPatients with HCC were analyzed from Januar...

Full description

Bibliographic Details
Main Authors: Peng Guo, Xingtao Pi, Feng Gao, Qiang Li, Duqiang Li, Wendong Feng, Wendong Cao
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Series:Frontiers in Oncology
Subjects:
hepatocellular carcinoma
lenvatinib
TACE
PD-1
unresectable
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.945915/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.945915/full

Similar Items